Laboratory-developed Testing market is estimated at $11.52 billion in 2016 and is expected to reach $18.92 billion by 2023 growing at a CAGR of 7.3% 2023

PUNE, INDIA, September 7, 2017 /EINPresswire.com/ --

Summary

According to Stratistics MRC, the Global Laboratory-developed Testing market is estimated at $11.52 billion in 2016 and is expected to reach $18.92 billion by 2023 growing at a CAGR of 7.3% from 2016 to 2023. Rising geriatric population and increase in personalised treatment are some of the major factors driving the market growth. Whereas stringent government approvals and high cost associated with the tests are hampering the market growth. In 2015, North America accounted for the highest market share as compared to other regions owing to the favourable reimbursement policies. The Asia Pacific region is expected to grow at a higher CAGR and is anticipated to account for the highest market share during forecast period because of increasing in ageing population in this region.

Some of the key players in the market include ARUP Laboratories, CardioDx, Citrano Medical Laboratories, Hendry Regional Medical Center Clinical Laboratory, Laboratory Corporation of America Holdings (LabCorp), Med Plus LLC, Myriad Genetic Laboratories Inc, Parkview Medical Center/Resp Care, Precision Therapeutics Inc., Quest Diagnostics, RedPath Integrated Pathology, Inc., Sequenom, Inc and Sharp Cornado Hosp & Healthcare Center.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1631167-laboratory-developed-testing-global-market-outlook-2017-2023

Type of Facilities Covered:
• Academic Institutes
• Clinical Research organizations
• Hospitals laboratory
• Specialty Diagnostic Centers
• Other Type of Facilities

Test Types Covered:
• Clinical Biochemistry
• Critical Care
• Haematology
• Immunology
• Microbiology
• Molecular Diagnostics
• Other Test Types

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments

At any Query @ https://www.wiseguyreports.com/enquiry/1631167-laboratory-developed-testing-global-market-outlook-2017-2023

Table of Contents

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Laboratory-developed Testing Market, By Type of Facility
5.1 Introduction
5.2 Academic Institutes
5.3 Clinical Research organizations
5.4 Hospitals laboratory
5.5 Specialty Diagnostic Centers
5.6 Other Type of Facilities

6 Global Laboratory-developed Testing Market, By Test Type
6.1 Introduction
6.2 Clinical Biochemistry
6.3 Critical Care
6.4 Haematology
6.5 Immunology
6.6 Microbiology
6.7 Molecular Diagnostics
6.8 Other Test Types

7 Global Laboratory-developed Testing Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 ARUP Laboratories
9.2 CardioDx
9.3 Citrano Medical Laboratories
9.4 Hendry Regional Medical Center Clinical Laboratory
9.5 Laboratory Corporation of America Holdings (LabCorp)
9.6 Med Plus LLC
9.7 Myriad Genetic Laboratories Inc
9.8 Parkview Medical Center/Resp Care
9.9 Precision Therapeutics Inc.
9.10 Quest Diagnostics
9.11 RedPath Integrated Pathology, Inc.
9.12 Sequenom, Inc.
9.13 Sharp Cornado Hosp & Healthcare Center

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1631167

Continued....

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here